Results 61 to 70 of about 119,049 (142)

[Clinical guideline of «congenital hypothyroidism»]. [PDF]

open access: yesProbl Endokrinol (Mosk), 2022
Peterkova VA   +10 more
europepmc   +1 more source

[A personalized, evidence-based approach to obesity therapy using clinical algorithms: semaglutide or tirzepatide]. [PDF]

open access: yesProbl Endokrinol (Mosk)
Troshina EA   +7 more
europepmc   +1 more source

Protocol deviations in medicine quality tests. [PDF]

open access: yesBull World Health Organ
Mulatsari E   +6 more
europepmc   +1 more source

Target product profile: diagnostic test for <i>Trypanosoma brucei gambiense</i>. [PDF]

open access: yesBull World Health Organ, 2023
Priotto G   +14 more
europepmc   +1 more source

[Fixed ratio combinations GLP-1RA and basal insulin: literature review]. [PDF]

open access: yesProbl Endokrinol (Mosk)
Kurkin DV   +10 more
europepmc   +1 more source

[Effect of bone anabolic therapy on bone remodeling and bone density in geriatric patients with osteoporosis and falling syndrome]. [PDF]

open access: yesProbl Endokrinol (Mosk), 2022
Khovasova NO   +5 more
europepmc   +1 more source

[The history of the pharmacotherapy of obesity]. [PDF]

open access: yesProbl Endokrinol (Mosk)
Berkovskaya MA   +3 more
europepmc   +1 more source

[Imeglimin: features of the mechanism of action and potential benefits]. [PDF]

open access: yesProbl Endokrinol (Mosk), 2022
Kuznetsov KO   +7 more
europepmc   +1 more source

[Features of the use of synthetic analogues of thyroid hormones: а 2020 THESIS* questionnaire survey of members of the Belarusian Public Medical Association of Endocrinology and Metabolism]. [PDF]

open access: yesProbl Endokrinol (Mosk), 2021
Shepelkevich AP   +9 more
europepmc   +1 more source

Single-step versus conventional injectable artesunate for severe malaria in children: an open label, non-inferiority randomized clinical trial, Democratic Republic of the Congo and United Republic of Tanzania. [PDF]

open access: yesBull World Health Organ
Gesase S   +22 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy